John’s commitment to his community mirrors his commitment to his longtime work in chemistry: he is always determined to make the world a better place, whether it be through educational efforts or advancements in biotechnology
Marietta, GA (PRWEB) November 08, 2012
John Blizzard, member and Lead Chemist of Kimmerling Holdings Group, LLC, and fiteBac SkinCare, LLC, was honored with the Jerome L. Yantz Partner in Education Award in Bay City, Michigan, this past Friday, November 2. The award recognized Mr. Blizzard’s commitment to the students of Bay City. The Bay Area Chamber presented the award to Mr. Blizzard during the Bay Area Chamber's Business and Education Partnership Conversation on Education luncheon on November 2.
Mr. Blizzard is a retired Dow Corning Corporation chemist with more than 50 patents to his name. He enjoyed a 35-year career at Dow Corning in Midland, Michigan, before he teamed up with Dr. Kirk Kimmerling DDS, cosmetic dentist Marietta, GA, and Mr. Daniel Kearney of Glen Mills, PA, to form Kimmerling Holdings Group, LLC, a Georgia-based biotechnology company with a novel antimicrobial platform technology. Mr. Blizzard was the key developer of fiteBac SkinCare Hand Softening Gel, the first product to market from KHG’s subsidiary company, fiteBac SkinCare.
“We are immensely proud of John and his dedication to his community,” said Dr. Kirk Kimmerling, DDS, co-founder and CEO of Kimmerling Holdings Group, LLC, of which Mr. Blizzard is a partner. "John’s commitment to his community mirrors his commitment to his longtime work in chemistry: he is always determined to make the world a better place, whether it be through educational efforts or advancements in biotechnology.”
Mr. Blizzard’s current work with Kimmerling Holdings Group focuses around applications for KHG’s antimicrobial platform technology and fiteBac SkinCare’s Germicidal Hand Softening Gel. The end goal of all KHG fiteBac ventures is to make the world a healthier, more cost-effective place. The fiteBac SkinCare Germicidal Hand Softening Gel has garnered rave reviews from healthcare professionals and industry-leading evaluators and publications. Highly reputed infection control expert Dr. John Molinari of THE DENTAL ADVISOR recently conducted a product analysis of the fiteBac hand gel in which fiteBac was shown to exhibit high levels of germicidal activity. fiteBac SkinCare Germicidal Hand Softening Gel is the first fiteBac product to market. Kimmerling Holdings Group technology applications are forthcoming.
For more information on Kimmerling Holdings Group, LLC, visit http://www.kimmerlingholdingsgroup.com/.
For more information on fiteBac SkinCare, visit http://www.fitebac.com.
About fiteBac™ SkinCare, LLC, and KHG: fiteBac SkinCare, LLC, is a subsidiary company of Kimmerling Holdings Group, LLC (“KHG”), a Georgia-based biotech company that has developed an antimicrobial platform intellectual property technology. KHG was founded in 2009 by Marietta dentist Kirk Kimmerling, DDS, and Dan Kearney. The two set out to create products that would "change the world, one product at a time." Kirk and Dan first targeted bacterial issues in dentistry, knowing that solving those problems would lead to dramatic improvements in oral health and, more importantly, systemic bodily health. They engaged a team of highly accomplished chemists and scientists retired from Fortune 500 companies and researchers from major universities. In doing so, KHG has developed technology with several patents pending that has application well beyond dental materials and has exciting potential in medical, plastic, composite, coating, and other applications that are in various stages of development. fiteBac SkinCare Hand Softening Gel is the first product to be released under the fiteBac brand name. To learn more about fiteBac SkinCare Germicidal Hand Softening Gel, watch fiteBac's Germicidal Hand Gel video. For more information on the Marietta emergency dentist and cosmetic dentist, Kirk Kimmerling DDS, click here.